Beta-carotene supplements (with or without vitamin A) increased lung cancer and mortality in smokers and asbestos-exposed workers (CARET, ATBC), and the USPSTF recommends against them.
Original statement
وفي السرطان، أوقفت تجربة CARET عام 1996 مبكراً بعد أن رفع البيتا كاروتين وفيتامين A الإصابةَ بسرطان الرئة لدى المدخنين بنسبة 28%، وأكدت تجربة ATBC الفنلندية النتيجة نفسها. أما تجربة SELECT فأظهرت أن فيتامين E بجرعة 400 وحدة دولية يومياً يزيد سرطان البروستاتا بنسبة 17%.
not verbatim – paraphrase. Translation by the project; the Arabic wording is authoritative.
Translation
Beta-carotene supplements (with or without vitamin A) increased lung cancer and mortality in smokers and asbestos-exposed workers (CARET, ATBC), and the USPSTF recommends against them.
Origin
- Source status
- Archive editors
- Attribution
- Archive editors (eltayebat.com); not verified as Elawady's own words
- Origin
- https://eltayebat.com/rule/oral-supplements/
- Attribution uncertainty
- Written by the archive operators; study selection is the archive's, not necessarily Elawady's.
- Claimed mechanism
Not specified.
- Claimed health effect
Lung cancer, total mortality.
- Population concerned
Smokers, former smokers, asbestos workers.
- Geographic restriction by Elawady
none found
Scientific assessment
True – The statement is supported by robust evidence.
Certainty of evidence: high – Further research is very unlikely to change the assessment.
1. What was claimed?
Beta-carotene pills raise lung cancer risk in smokers.
2. What is demonstrably correct?
Correct: CARET RR 1.28 (1.04–1.57) for lung cancer and RR 1.17 for death from any cause; ATBC 18% higher lung cancer incidence and 8% higher total mortality with beta-carotene; USPSTF 2022 recommends against beta-carotene.
3. What is wrong or exaggerated?
Nothing substantial; 'confirmed the same verdict' should note that ATBC used beta-carotene alone and found no benefit of alpha-tocopherol on lung cancer.
4. What remains unclear?
Mechanism unclear.
5. Which studies support it?
A-SUP-04, A-SUP-05, A-SUP-24, A-SUP-30, I-SUP-08.
6. Which studies contradict it?
None.
7. What applies to Germany and Europe?
Applies equally.
8. What is known about Egypt?
Applies equally; smoking prevalence matters.
9. What practical conclusion is appropriate?
Smokers should not take beta-carotene supplements; vegetables and fruit containing carotenoids are a different matter.
Assessment details
- Rationale for certainty of evidence
Two large double-blind RCTs (18,314 and 29,133 participants) with consistent findings; pooled in USPSTF 2022 review (lung cancer OR 1.20; CV mortality OR 1.10); USPSTF D recommendation.
- Source quality
Correctly cited RCTs.
- Regional transferability
High.
- Individual exceptions
Findings are strongest in smokers; dietary beta-carotene from foods is a different exposure.
- Regional scope of the claim
- general (biological/medical)
- Last reviewed
- 25 October 2026 provisional
In plain language
Two large trials gave smokers beta-carotene pills hoping to prevent lung cancer. Instead, more of them got lung cancer and died. US prevention experts therefore advise against these pills. This claim is correct.
Studies on this claim
Studies supporting the claim (5)
-
CARET: beta-carotene and vitamin A raised lung cancer in smokers
Omenn GS et al.. N Engl J Med 1996 · PMID 8602180 · DOI 10.1056/NEJM199605023341802Randomised controlled trialcited by the Tayebat archiveabstract only checked★ key studyLung cancer was 28% more frequent with the supplements; the trial was stopped early.
Does the study support the specific claim? Yes · Methodological quality: high · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Prevent lung cancer?
- How was the study done?
RCT.
- How many people, animals or samples were studied?
18,314 high-risk adults.
- What was actually found?
More lung cancer, more deaths.
- How large was the observed effect?
RR 1.28; 1.17.
- What do the results mean in everyday life?
Smokers should avoid beta-carotene pills.
- What are the study's limitations?
Early stopping.
- What does it say about Elawady's specific claim?
Supports.
- Do the results apply to Germany and Europe?
Applicable.
- What can explicitly not be concluded from this study?
Effect in non-smokers.
-
ATBC: beta-carotene raised lung cancer in Finnish smokers
ATBC Study Group. N Engl J Med 1994 · PMID 8127329 · DOI 10.1056/NEJM199404143301501Randomised controlled trialcited by the Tayebat archiveabstract only checkedBeta-carotene raised lung cancer by 18% and deaths by 8%; vitamin E did not prevent lung cancer.
Does the study support the specific claim? Yes · Methodological quality: high · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Cancer prevention in smokers.
- How was the study done?
Factorial RCT.
- How many people, animals or samples were studied?
29,133 men.
- What was actually found?
Harm from beta-carotene.
- How large was the observed effect?
+18% lung cancer.
- What do the results mean in everyday life?
Avoid beta-carotene pills.
- What are the study's limitations?
Men smokers only.
- What does it say about Elawady's specific claim?
Supports C-SUP-02.
- Do the results apply to Germany and Europe?
Applicable.
- What can explicitly not be concluded from this study?
Non-smokers.
-
Antioxidant pills and mortality
Bjelakovic G et al.. JAMA 2007 · PMID 17327526 · DOI 10.1001/jama.297.8.842Meta-analysiscited by the Tayebat archiveabstract only checked★ key studyIn low-bias trials, beta-carotene, vitamin A and vitamin E were linked to slightly more deaths.
Does the study support the specific claim? Partly · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Mortality.
- How was the study done?
Meta-analysis.
- How many people, animals or samples were studied?
232,606.
- What was actually found?
Small increase in low-bias trials.
- How large was the observed effect?
RR 1.05.
- What do the results mean in everyday life?
No benefit, possible harm.
- What are the study's limitations?
Debated methods.
- What does it say about Elawady's specific claim?
Supports.
- Do the results apply to Germany and Europe?
Applicable.
- What can explicitly not be concluded from this study?
Precise harm.
-
USPSTF 2022: vitamins for prevention
US Preventive Services Task Force et al.. JAMA 2022 · PMID 35727271 · DOI 10.1001/jama.2022.8970Guideline / position statementcited by the Tayebat archiveabstract only checked★ key studyRecommends against beta-carotene and vitamin E; evidence insufficient for most others.
Does the study support the specific claim? Yes · Methodological quality: high · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Prevention guidance.
- How was the study done?
Guideline.
- What was actually found?
D for beta-carotene, vitamin E; I for others.
- What do the results mean in everyday life?
Don't take for prevention.
- What are the study's limitations?
Not for pregnancy/deficiency.
- What does it say about Elawady's specific claim?
Supports.
- Do the results apply to Germany and Europe?
Applicable.
- What can explicitly not be concluded from this study?
Advice on deficiency or pregnancy.
-
USPSTF evidence review 2022
O'Connor EA et al.. JAMA 2022 · PMID 35727272 · DOI 10.1001/jama.2021.15650Systematic reviewindependent cross-checkabstract only checked★ key studySupplements gave little or no protection; beta-carotene harmful; multivitamins slightly fewer cancers.
Does the study support the specific claim? Partly · Methodological quality: high · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Supplement benefits/harms.
- How was the study done?
SR.
- How many people, animals or samples were studied?
739,803.
- What was actually found?
Little benefit; some harms.
- How large was the observed effect?
OR 0.93 MV cancer; 1.20 beta-carotene lung cancer.
- What do the results mean in everyday life?
Supplements are not a prevention strategy.
- What are the study's limitations?
Not for deficiency.
- What does it say about Elawady's specific claim?
Mixed.
- Do the results apply to Germany and Europe?
Applicable.
- What can explicitly not be concluded from this study?
Effects in deficient people.
No study in this group is marked as key.
Studies contradicting or limiting the claim (0)
No studies in this group.
Studies with mixed or unclear results (0)
No studies in this group.
Regional context
Germany / EU
Applies equally.
Egypt
Applies equally; smoking prevalence matters.
What applies in my country?
General scientific assessment
True True: beta-carotene pills increased lung cancer in smokers.
This statement concerns biological or medical relationships. The scientific assessment above applies regardless of the country; country-specific food data do not change it.
References
- Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease.. Omenn GS et al.. N Engl J Med 1996 · PMID 8602180 · DOI 10.1056/NEJM199605023341802
- The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers.. ATBC Study Group. N Engl J Med 1994 · PMID 8127329 · DOI 10.1056/NEJM199404143301501
- Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis.. Bjelakovic G et al.. JAMA 2007 · PMID 17327526 · DOI 10.1001/jama.297.8.842
- Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: US Preventive Services Task Force Recommendation Statement.. US Preventive Services Task Force et al.. JAMA 2022 · PMID 35727271 · DOI 10.1001/jama.2022.8970
- Vitamin and Mineral Supplements for the Primary Prevention of Cardiovascular Disease and Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.. O'Connor EA et al.. JAMA 2022 · PMID 35727272 · DOI 10.1001/jama.2021.15650